TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07816172: A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Macanity on Urinary Health in Males Experiencing Lower Urinary Tract Symptoms

Sponsor: RDC Clinical Pty Ltd · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 200 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07816172 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07816172 Rescue Dossier →